234 related articles for article (PubMed ID: 17348856)
1. Pharmacophore modeling in drug discovery and development: an overview.
Khedkar SA; Malde AK; Coutinho EC; Srivastava S
Med Chem; 2007 Mar; 3(2):187-97. PubMed ID: 17348856
[TBL] [Abstract][Full Text] [Related]
2. History and evolution of the pharmacophore concept in computer-aided drug design.
Güner OF
Curr Top Med Chem; 2002 Dec; 2(12):1321-32. PubMed ID: 12470283
[TBL] [Abstract][Full Text] [Related]
3. Pharmacophore modeling and three-dimensional database searching for drug design using catalyst.
Kurogi Y; Güner OF
Curr Med Chem; 2001 Jul; 8(9):1035-55. PubMed ID: 11472240
[TBL] [Abstract][Full Text] [Related]
4. Pharmacophore discovery--lessons learned.
van Drie JH
Curr Pharm Des; 2003; 9(20):1649-64. PubMed ID: 12871063
[TBL] [Abstract][Full Text] [Related]
5. The Pharmacophore Concept and Its Applications in Computer-Aided Drug Design.
Seidel T; Schuetz DA; Garon A; Langer T
Prog Chem Org Nat Prod; 2019; 110():99-141. PubMed ID: 31621012
[TBL] [Abstract][Full Text] [Related]
6. New features that improve the pharmacophore tools from Accelrys.
Sutter J; Li J; Maynard AJ; Goupil A; Luu T; Nadassy K
Curr Comput Aided Drug Des; 2011 Sep; 7(3):173-80. PubMed ID: 21726193
[TBL] [Abstract][Full Text] [Related]
7. Pharmacophore modeling and applications in drug discovery: challenges and recent advances.
Yang SY
Drug Discov Today; 2010 Jun; 15(11-12):444-50. PubMed ID: 20362693
[TBL] [Abstract][Full Text] [Related]
8. New 4-point pharmacophore method for molecular similarity and diversity applications: overview of the method and applications, including a novel approach to the design of combinatorial libraries containing privileged substructures.
Mason JS; Morize I; Menard PR; Cheney DL; Hulme C; Labaudiniere RF
J Med Chem; 1999 Aug; 42(17):3251-64. PubMed ID: 10464012
[TBL] [Abstract][Full Text] [Related]
9. Molecule-pharmacophore superpositioning and pattern matching in computational drug design.
Wolber G; Seidel T; Bendix F; Langer T
Drug Discov Today; 2008 Jan; 13(1-2):23-9. PubMed ID: 18190860
[TBL] [Abstract][Full Text] [Related]
10. Deterministic pharmacophore detection via multiple flexible alignment of drug-like molecules.
Schneidman-Duhovny D; Dror O; Inbar Y; Nussinov R; Wolfson HJ
J Comput Biol; 2008 Sep; 15(7):737-54. PubMed ID: 18662104
[TBL] [Abstract][Full Text] [Related]
11. A comparison of the pharmacophore identification programs: Catalyst, DISCO and GASP.
Patel Y; Gillet VJ; Bravi G; Leach AR
J Comput Aided Mol Des; 2002; 16(8-9):653-81. PubMed ID: 12602956
[TBL] [Abstract][Full Text] [Related]
12. The Development of Pharmacophore Modeling: Generation and Recent Applications in Drug Discovery.
Lu X; Yang H; Chen Y; Li Q; He SY; Jiang X; Feng F; Qu W; Sun H
Curr Pharm Des; 2018; 24(29):3424-3439. PubMed ID: 30101699
[TBL] [Abstract][Full Text] [Related]
13. Recent advances in ligand-based drug design: relevance and utility of the conformationally sampled pharmacophore approach.
Acharya C; Coop A; Polli JE; Mackerell AD
Curr Comput Aided Drug Des; 2011 Mar; 7(1):10-22. PubMed ID: 20807187
[TBL] [Abstract][Full Text] [Related]
14. Novel 2D fingerprints for ligand-based virtual screening.
Ewing T; Baber JC; Feher M
J Chem Inf Model; 2006; 46(6):2423-31. PubMed ID: 17125184
[TBL] [Abstract][Full Text] [Related]
15. Fuzzy tricentric pharmacophore fingerprints. 1. Topological fuzzy pharmacophore triplets and adapted molecular similarity scoring schemes.
Bonachéra F; Parent B; Barbosa F; Froloff N; Horvath D
J Chem Inf Model; 2006; 46(6):2457-77. PubMed ID: 17125187
[TBL] [Abstract][Full Text] [Related]
16. Pharmacophore-based virtual screening.
Horvath D
Methods Mol Biol; 2011; 672():261-98. PubMed ID: 20838973
[TBL] [Abstract][Full Text] [Related]
17. 3D-QSAR study of corticotropin-releasing factor 1 antagonists and pharmacophore-based drug design.
Ye Y; Liao Q; Wei J; Gao Q
Neurochem Int; 2010 Jan; 56(1):107-17. PubMed ID: 19782115
[TBL] [Abstract][Full Text] [Related]
18. Pharmacophore modeling and three dimensional database searching for drug design using catalyst: recent advances.
Güner O; Clement O; Kurogi Y
Curr Med Chem; 2004 Nov; 11(22):2991-3005. PubMed ID: 15544485
[TBL] [Abstract][Full Text] [Related]
19. Pharmacophore based drug design approach as a practical process in drug discovery.
Gao Q; Yang L; Zhu Y
Curr Comput Aided Drug Des; 2010 Mar; 6(1):37-49. PubMed ID: 20370694
[TBL] [Abstract][Full Text] [Related]
20. Identification of the descriptor pharmacophores using variable selection QSAR: applications to database mining.
Tropsha A; Zheng W
Curr Pharm Des; 2001 May; 7(7):599-612. PubMed ID: 11375770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
